Clinical benefit of low molecular weight heparin for ST-segment elevation myocardial infarction patients undergoing primary percutaneous coronary intervention with glycoprotein IIb/IIIa inhibitor.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples